Global mRNA Vaccines for Infectious Diseases Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global mRNA Vaccines for Infectious Diseases Market Size 2017-2028

2.1.2 mRNA Vaccines for Infectious Diseases Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 mRNA Vaccines for Infectious Diseases Segment by Type

2.2.1 Infectious Disease Vaccines

2.2.2 Cancer Vaccines

2.3 mRNA Vaccines for Infectious Diseases Market Size by Type

2.3.1 mRNA Vaccines for Infectious Diseases Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2022)

2.4 mRNA Vaccines for Infectious Diseases Segment by Application

2.4.1 Infectious Disease

2.4.2 Cancer

2.5 mRNA Vaccines for Infectious Diseases Market Size by Application

2.5.1 mRNA Vaccines for Infectious Diseases Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2022)

3 mRNA Vaccines for Infectious Diseases Market Size by Player

3.1 mRNA Vaccines for Infectious Diseases Market Size Market Share by Players

3.1.1 Global mRNA Vaccines for Infectious Diseases Revenue by Players (2020-2022)

3.1.2 Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Players (2020-2022)

3.2 Global mRNA Vaccines for Infectious Diseases Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 mRNA Vaccines for Infectious Diseases by Regions

4.1 mRNA Vaccines for Infectious Diseases Market Size by Regions (2017-2022)

4.2 Americas mRNA Vaccines for Infectious Diseases Market Size Growth (2017-2022)

4.3 APAC mRNA Vaccines for Infectious Diseases Market Size Growth (2017-2022)

4.4 Europe mRNA Vaccines for Infectious Diseases Market Size Growth (2017-2022)

4.5 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Growth (2017-2022)

5 Americas

5.1 Americas mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)

5.2 Americas mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)

5.3 Americas mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2022)

6.2 APAC mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)

6.3 APAC mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe mRNA Vaccines for Infectious Diseases by Country (2017-2022)

7.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)

7.3 Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa mRNA Vaccines for Infectious Diseases by Region (2017-2022)

8.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)

8.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global mRNA Vaccines for Infectious Diseases Market Forecast

10.1 Global mRNA Vaccines for Infectious Diseases Forecast by Regions (2023-2028)

10.1.1 Global mRNA Vaccines for Infectious Diseases Forecast by Regions (2023-2028)

10.1.2 Americas mRNA Vaccines for Infectious Diseases Forecast

10.1.3 APAC mRNA Vaccines for Infectious Diseases Forecast

10.1.4 Europe mRNA Vaccines for Infectious Diseases Forecast

10.1.5 Middle East & Africa mRNA Vaccines for Infectious Diseases Forecast

10.2 Americas mRNA Vaccines for Infectious Diseases Forecast by Country (2023-2028)

10.2.1 United States mRNA Vaccines for Infectious Diseases Market Forecast

10.2.2 Canada mRNA Vaccines for Infectious Diseases Market Forecast

10.2.3 Mexico mRNA Vaccines for Infectious Diseases Market Forecast

10.2.4 Brazil mRNA Vaccines for Infectious Diseases Market Forecast

10.3 APAC mRNA Vaccines for Infectious Diseases Forecast by Region (2023-2028)

10.3.1 China mRNA Vaccines for Infectious Diseases Market Forecast

10.3.2 Japan mRNA Vaccines for Infectious Diseases Market Forecast

10.3.3 Korea mRNA Vaccines for Infectious Diseases Market Forecast

10.3.4 Southeast Asia mRNA Vaccines for Infectious Diseases Market Forecast

10.3.5 India mRNA Vaccines for Infectious Diseases Market Forecast

10.3.6 Australia mRNA Vaccines for Infectious Diseases Market Forecast

10.4 Europe mRNA Vaccines for Infectious Diseases Forecast by Country (2023-2028)

10.4.1 Germany mRNA Vaccines for Infectious Diseases Market Forecast

10.4.2 France mRNA Vaccines for Infectious Diseases Market Forecast

10.4.3 UK mRNA Vaccines for Infectious Diseases Market Forecast

10.4.4 Italy mRNA Vaccines for Infectious Diseases Market Forecast

10.4.5 Russia mRNA Vaccines for Infectious Diseases Market Forecast

10.5 Middle East & Africa mRNA Vaccines for Infectious Diseases Forecast by Region (2023-2028)

10.5.1 Egypt mRNA Vaccines for Infectious Diseases Market Forecast

10.5.2 South Africa mRNA Vaccines for Infectious Diseases Market Forecast

10.5.3 Israel mRNA Vaccines for Infectious Diseases Market Forecast

10.5.4 Turkey mRNA Vaccines for Infectious Diseases Market Forecast

10.5.5 GCC Countries mRNA Vaccines for Infectious Diseases Market Forecast

10.6 Global mRNA Vaccines for Infectious Diseases Forecast by Type (2023-2028)

10.7 Global mRNA Vaccines for Infectious Diseases Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Moderna Therapeutics

11.1.1 Moderna Therapeutics Company Information

11.1.2 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product Offered

11.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Moderna Therapeutics Main Business Overview

11.1.5 Moderna Therapeutics Latest Developments

11.2 CureVac

11.2.1 CureVac Company Information

11.2.2 CureVac mRNA Vaccines for Infectious Diseases Product Offered

11.2.3 CureVac mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 CureVac Main Business Overview

11.2.5 CureVac Latest Developments

11.3 Translate Bio

11.3.1 Translate Bio Company Information

11.3.2 Translate Bio mRNA Vaccines for Infectious Diseases Product Offered

11.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Translate Bio Main Business Overview

11.3.5 Translate Bio Latest Developments

11.4 BioNTech

11.4.1 BioNTech Company Information

11.4.2 BioNTech mRNA Vaccines for Infectious Diseases Product Offered

11.4.3 BioNTech mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 BioNTech Main Business Overview

11.4.5 BioNTech Latest Developments

11.5 Sangamo Therapeutics

11.5.1 Sangamo Therapeutics Company Information

11.5.2 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product Offered

11.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Sangamo Therapeutics Main Business Overview

11.5.5 Sangamo Therapeutics Latest Developments

11.6 Argos Therapeutics

11.6.1 Argos Therapeutics Company Information

11.6.2 Argos Therapeutics mRNA Vaccines for Infectious Diseases Product Offered

11.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Argos Therapeutics Main Business Overview

11.6.5 Argos Therapeutics Latest Developments

11.7 In-Cell-Art

11.7.1 In-Cell-Art Company Information

11.7.2 In-Cell-Art mRNA Vaccines for Infectious Diseases Product Offered

11.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 In-Cell-Art Main Business Overview

11.7.5 In-Cell-Art Latest Developments

11.8 eTheRNA

11.8.1 eTheRNA Company Information

11.8.2 eTheRNA mRNA Vaccines for Infectious Diseases Product Offered

11.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 eTheRNA Main Business Overview

11.8.5 eTheRNA Latest Developments

11.9 Ethris

11.9.1 Ethris Company Information

11.9.2 Ethris mRNA Vaccines for Infectious Diseases Product Offered

11.9.3 Ethris mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Ethris Main Business Overview

11.9.5 Ethris Latest Developments

11.10 Tiba Biotechnology

11.10.1 Tiba Biotechnology Company Information

11.10.2 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product Offered

11.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Tiba Biotechnology Main Business Overview

11.10.5 Tiba Biotechnology Latest Developments

12 Research Findings and Conclusion

Table 1. mRNA Vaccines for Infectious Diseases Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Infectious Disease Vaccines

Table 3. Major Players of Cancer Vaccines

Table 4. mRNA Vaccines for Infectious Diseases Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2022)

Table 7. mRNA Vaccines for Infectious Diseases Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2022)

Table 10. Global mRNA Vaccines for Infectious Diseases Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Player (2020-2022)

Table 12. mRNA Vaccines for Infectious Diseases Key Players Head office and Products Offered

Table 13. mRNA Vaccines for Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global mRNA Vaccines for Infectious Diseases Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Regions (2017-2022)

Table 18. Americas mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas mRNA Vaccines for Infectious Diseases Market Size Market Share by Country (2017-2022)

Table 20. Americas mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2022)

Table 22. Americas mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2022)

Table 24. APAC mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Region (2017-2022)

Table 26. APAC mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2022)

Table 28. APAC mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2022)

Table 30. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Country (2017-2022)

Table 32. Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2022)

Table 34. Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of mRNA Vaccines for Infectious Diseases

Table 43. Key Market Challenges & Risks of mRNA Vaccines for Infectious Diseases

Table 44. Key Industry Trends of mRNA Vaccines for Infectious Diseases

Table 45. Global mRNA Vaccines for Infectious Diseases Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global mRNA Vaccines for Infectious Diseases Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global mRNA Vaccines for Infectious Diseases Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global mRNA Vaccines for Infectious Diseases Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global mRNA Vaccines for Infectious Diseases Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global mRNA Vaccines for Infectious Diseases Market Size Market Share Forecast by Application (2023-2028)

Table 51. Moderna Therapeutics Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors

Table 52. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product Offered

Table 53. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Moderna Therapeutics Main Business

Table 55. Moderna Therapeutics Latest Developments

Table 56. CureVac Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors

Table 57. CureVac mRNA Vaccines for Infectious Diseases Product Offered

Table 58. CureVac Main Business

Table 59. CureVac mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. CureVac Latest Developments

Table 61. Translate Bio Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors

Table 62. Translate Bio mRNA Vaccines for Infectious Diseases Product Offered

Table 63. Translate Bio Main Business

Table 64. Translate Bio mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Translate Bio Latest Developments

Table 66. BioNTech Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors

Table 67. BioNTech mRNA Vaccines for Infectious Diseases Product Offered

Table 68. BioNTech Main Business

Table 69. BioNTech mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. BioNTech Latest Developments

Table 71. Sangamo Therapeutics Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors

Table 72. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product Offered

Table 73. Sangamo Therapeutics Main Business

Table 74. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Sangamo Therapeutics Latest Developments

Table 76. Argos Therapeutics Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors

Table 77. Argos Therapeutics mRNA Vaccines for Infectious Diseases Product Offered

Table 78. Argos Therapeutics Main Business

Table 79. Argos Therapeutics mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Argos Therapeutics Latest Developments

Table 81. In-Cell-Art Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors

Table 82. In-Cell-Art mRNA Vaccines for Infectious Diseases Product Offered

Table 83. In-Cell-Art Main Business

Table 84. In-Cell-Art mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. In-Cell-Art Latest Developments

Table 86. eTheRNA Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors

Table 87. eTheRNA mRNA Vaccines for Infectious Diseases Product Offered

Table 88. eTheRNA Main Business

Table 89. eTheRNA mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. eTheRNA Latest Developments

Table 91. Ethris Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors

Table 92. Ethris mRNA Vaccines for Infectious Diseases Product Offered

Table 93. Ethris Main Business

Table 94. Ethris mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Ethris Latest Developments

Table 96. Tiba Biotechnology Details, Company Type, mRNA Vaccines for Infectious Diseases Area Served and Its Competitors

Table 97. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product Offered

Table 98. Tiba Biotechnology Main Business

Table 99. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Tiba Biotechnology Latest Developments

List of Figures

Figure 1. mRNA Vaccines for Infectious Diseases Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Type in 2021

Figure 7. mRNA Vaccines for Infectious Diseases in Infectious Disease

Figure 8. Global mRNA Vaccines for Infectious Diseases Market: Infectious Disease (2017-2022) & ($ Millions)

Figure 9. mRNA Vaccines for Infectious Diseases in Cancer

Figure 10. Global mRNA Vaccines for Infectious Diseases Market: Cancer (2017-2022) & ($ Millions)

Figure 11. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Application in 2021

Figure 12. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Player in 2021

Figure 13. Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Regions (2017-2022)

Figure 14. Americas mRNA Vaccines for Infectious Diseases Market Size 2017-2022 ($ Millions)

Figure 15. APAC mRNA Vaccines for Infectious Diseases Market Size 2017-2022 ($ Millions)

Figure 16. Europe mRNA Vaccines for Infectious Diseases Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size 2017-2022 ($ Millions)

Figure 18. Americas mRNA Vaccines for Infectious Diseases Value Market Share by Country in 2021

Figure 19. Americas mRNA Vaccines for Infectious Diseases Consumption Market Share by Type in 2021

Figure 20. Americas mRNA Vaccines for Infectious Diseases Market Size Market Share by Application in 2021

Figure 21. United States mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Region in 2021

Figure 26. APAC mRNA Vaccines for Infectious Diseases Market Size Market Share by Application in 2021

Figure 27. China mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 31. India mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Country in 2021

Figure 34. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Type in 2021

Figure 35. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Application in 2021

Figure 36. Germany mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 37. France mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Application in 2021

Figure 44. Egypt mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country mRNA Vaccines for Infectious Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 50. APAC mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 51. Europe mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 53. United States mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 54. Canada mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 55. Mexico mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 56. Brazil mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 57. China mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 58. Japan mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 59. Korea mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 61. India mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 62. Australia mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 63. Germany mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 64. France mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 65. UK mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 66. Italy mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 67. Russia mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 68. Spain mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 69. Egypt mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 70. South Africa mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 71. Israel mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 72. Turkey mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries mRNA Vaccines for Infectious Diseases Market Size 2023-2028 ($ Millions)